Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months)-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months)

Published:2017-12 Issue: Volume:14 Page:108-115
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Felipe Claudia,Tedesco-Silva Helio,Ferreira Brigido Alexandra,Bessa Adrieli,Ruppel Priscila,Hiramoto Liliane,de Paula Mayara,Cristelli Marina,Stopa Suelen,Mansur Juliana,Viana Laila,Fahham Lucas,Pepe Camila,Medina-Pestana Jose

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference24 articles.

1. End-stage renal disease in the developing world;Barsoum;Artif Organs,2002

2. Overview: end-stage renal disease in the developing world;Barsoum;Artif Organs,2002

3. Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany;Jürgensen;Eur J Health Econ,2015

4. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection;Marcén;Drugs,2009

5. The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis;Schnitzler;Am J Transplant,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Pharmacological Treatment for Adult Kidney Transplant Recipients in Colombia;Value in Health Regional Issues;2024-07

2. Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring;Frontiers in Transplantation;2023-10-16

3. A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial;Transplantation;2023-08-01

4. Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial;Transplantation;2023-07-20

5. A Systematic Review of Kidney Transplantation Decision Modelling Studies;Applied Health Economics and Health Policy;2022-08-09